Trung tâm Thông tin - Thư viện Trường Đại học Y Dược Hải Phòng

NLM	C29
Tác giả CN	Nguyễn Thị Thu Hiền
Nhan đề	Antiviral treatment for viral pneumonia: current drugs and natural compounds
Thông tin xuất bản	2025
Thông tin xuất bản	London: BioMed Central
Tóm tắt	In recent years, viral pneumonia has become a significant challenge to global public health, particularly during the COVID-19 pandemic. Viral pneumonia can be caused by various viruses, including influenza virus, RSV, and adenovirus. These viruses trigger inflammatory responses by invading the respiratory epithelial cells, leading to lung damage. Existing antiviral drugs such as ribavirin, adobiravir, and oseltamivir exert their therapeutic effects by inhibiting different stages of the viral life cycle but face issues such as increasing drug resistance. Natural components like astragalus saponins, Houttuynia cordata flavonoids, and tea theaflavin-gallates have demonstrated supportive roles in antiviral treatments, capable of not only enhancing immune responses but also potentially inhibiting viral replication through multiple pathways, thereby alleviating lung damage. Although natural components cannot entirely replace traditional antiviral drugs, their role in comprehensive treatment regimens is becoming increasingly important
Thuật ngữ chủ đề	Traditional medicine
Từ khóa tự do	Antiviral drugs; Natural compounds
Địa chỉ	100Kho Bài báo quốc tế(1): BQT00027
Tệp tin điện tử	https://pubmed.ncbi.nlm.nih.gov/40050867/
Tệp tin điện tử	https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg

MARC

Hiển thị đầy đủ trường & trường con

Tag	Giá trị
000	00000nab#a2200000ui#4500
001	33935
002	13
004	74246898-2B68-4711-A99D-F042C7550D8E
005	202605111645
008	081223s2025 vm\| vie
009	1 0
039	[ ] \|a 20260511164546 \|b phuongntt \|y 20260511164151 \|z phuongntt
041	[ ] \|a Eng
084	[ ] \|a C29
100	[ ] \|a Nguyễn Thị Thu Hiền
245	[ ] \|a Antiviral treatment for viral pneumonia: current drugs and natural compounds
260	[ ] \|c 2025
260	[ ] \|b London: BioMed Central
520	[ ] \|a In recent years, viral pneumonia has become a significant challenge to global public health, particularly during the COVID-19 pandemic. Viral pneumonia can be caused by various viruses, including influenza virus, RSV, and adenovirus. These viruses trigger inflammatory responses by invading the respiratory epithelial cells, leading to lung damage. Existing antiviral drugs such as ribavirin, adobiravir, and oseltamivir exert their therapeutic effects by inhibiting different stages of the viral life cycle but face issues such as increasing drug resistance. Natural components like astragalus saponins, Houttuynia cordata flavonoids, and tea theaflavin-gallates have demonstrated supportive roles in antiviral treatments, capable of not only enhancing immune responses but also potentially inhibiting viral replication through multiple pathways, thereby alleviating lung damage. Although natural components cannot entirely replace traditional antiviral drugs, their role in comprehensive treatment regimens is becoming increasingly important
650	[ ] \|a Traditional medicine
653	[ ] \|a Antiviral drugs
653	[ ] \|a Natural compounds
773	[ ] \|t Molecular Biology Reports
852	[ ] \|a 100 \|b Kho Bài báo quốc tế \|j (1): BQT00027
856	[ ] \|u https://pubmed.ncbi.nlm.nih.gov/40050867/
856	[1 ] \|u https://lib.hpmu.edu.vn/kiposdata2/tapchi2026/anhbiatc/biabbqt_thumbimage.jpg
890	[ ] \|a 1 \|b 0 \|c 0 \|d 0

Dòng	Mã vạch	Bản sao	Nơi lưu	Tình trạng	Cho phép yêu cầu
1	BQT00027	1	Kho Bài báo quốc tế
#1 BQT00027 Nơi lưu Kho Bài báo quốc tế Tình trạng

Bình luận